News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Neogenix Oncology, Inc.'s Novel Antibody NEO-101 Named One of Windhover Information Inc.'s Top 10 Projects to Watch


11/30/2011 8:55:38 AM

ROCKVILLE, Md.--(BUSINESS WIRE)--Neogenix Oncology, Inc. has announced that the company’s novel antibody NEO-101, which targets pancreatic and colorectal cancer cells, has been selected as one of Windhover’s 2011 Top 10 Projects to Watch.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES